Navigation Links
Nonin Medical's Onyx(R) II, Model 9560 Receives Bluetooth SIG's Best of CES 2009 Award
Date:1/15/2009

MINNEAPOLIS, Jan. 15 /PRNewswire/ -- Nonin Medical, Inc., a leading innovator of physiological monitoring solutions, has been named recipient of the Bluetooth SIG Best of CES 2009 award for the Onyx(R) II, Model 9560 fingertip pulse oximeter. As the world's first wireless fingertip oximeter, the innovative device combines Bluetooth(R) wireless technology with the revolutionary Onyx(R) fingertip oximeter -- enabling individuals to accurately monitor vital signs.

(Photo: http://www.newscom.com/cgi-bin/prnh/20090115/AQTH040)

"As long time partners in telemedicine, Bluetooth SIG and Nonin Medical have played a significant role in the advancement of interoperable communication between health and consumer devices," said e- HEALTH Business Manager, Jayant Parthasarathy, Ph.D. "With the integration of Bluetooth(R) wireless technology into Nonin's monitoring devices, and the development of the Bluetooth Health Device (HDP), together, our innovations address the need for streamlined data delivery solutions in the healthcare arena."

The Onyx(R) II, Model 9560 with Bluetooth(R) wireless technology signifies a major step in the adoption of interoperable cross-industry standards in telemedicine. "With the rapidly rising cost of healthcare, there is tremendous pressure for solutions that simplify the secure exchange of information and promote patient participation," said Gary Tschautscher, President and C.E.O. of Nonin Medical. "The integration of Bluetooth(R) wireless technology in health monitoring devices provides the ability to monitor vital signs with much greater ease and flexibility." Nonin Medical's next-generation Bluetooth(R) wireless technology devices are designed to be compatible with open standards such as Continua, IEEE 11073 and the Bluetooth Health Device Profile (HDP).

To learn more about the On
'/>"/>

SOURCE Nonin Medical, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Nonin Medical Selects nParallel to Design and Craft its New Tradeshow Exhibit
2. U.S. Air Force Awards Noninvasive Medical Technologies $2.4 Million Contract
3. Nonin Medical, Inc. Showcases the First Pulse Oximeter Pre-Certified by the Continua Health Alliance
4. PET/CT scan could be valuable noninvasive tool for determining stages of ovarian cancer
5. Nonin(R) Medical Announces Strategic Relationship With Microsoft and its Microsoft HealthVault Platform
6. Nonin(R) Medical Pioneers First Interoperable, Wireless Fingertip Pulse Oximeter
7. Masimo Receives FDA Clearance for Noninvasive Total Hemoglobin
8. Noninvasive Procedures Show Promise for Esophageal Bleeding
9. Advancing Interoperability - Nonin(R) Medical Unveils Worlds First Bluetooth(R)-Enabled, Wireless Fingertip Pulse Oximeter
10. Nonin Medical, Inc. Is Recognized for Its Role in Promoting Interoperability
11. Cerimon to Conduct a Proof of Concept Study for Basiliximab for Noninfectious Uveitis, a Potentially Sight-Threatening Inflammation of the Eye
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/18/2013)... Vienna, VA (PRWEB) June 18, 2013 As ... the increase in need for surgical equipment during childbirth comes ... the child from within the mother when she is unable ... difficult deliveries, they are associated with higher rates of complication ... addition to being harmful to the mother and child, forceps ...
(Date:6/18/2013)... The Drug Delivery Partnering Terms and ... the drug delivery partnering deals and agreements entered into ... report provides a detailed understanding and analysis of how ... majority of deals are discovery or development stage whereby ... to license the license drug delivery technology. These deals ...
(Date:6/18/2013)... (PRWEB) June 18, 2013 Parker ... protecting the rights of victims injured by defective medical ... review of Medtronic’s Infuse bone graft products are now ... a medical journal, the two studies serve up two ... effectiveness” when comparing Infuse and the traditional bone graft; ...
(Date:6/18/2013)... ENT and Allergy Associates, LLP (ENTA) does not ... , New York/New Jersey’s premier ear, nose, throat, ... offering superior healthcare to children and adults in hundreds ... York area-only considers adding to its current footprint when ... the right communities to serve, the right locations from ...
(Date:6/18/2013)... (PRWEB) June 18, 2013 Biomet ... continue to move forward in a multidistrict litigation in ... LLP reports. According to court records, the litigation’s ... at which time the Court also convened a motions ... issues pertinent to the Biomet hip replacement litigation. ...
Breaking Medicine News(10 mins):Health News:Forceps Births Double, Obesity is Major Reason in Births Complications 2Health News:New Drug Delivery Partnering Terms and Agreements Market Study Report Available at MarketResearchReports.Biz 2Health News:New Drug Delivery Partnering Terms and Agreements Market Study Report Available at MarketResearchReports.Biz 3Health News:New Drug Delivery Partnering Terms and Agreements Market Study Report Available at MarketResearchReports.Biz 4Health News:Yale Releases the Findings of the Medtronic-Commissioned Infuse Bone Graft Study; Parker Waichman LLP Comments 2Health News:Yale Releases the Findings of the Medtronic-Commissioned Infuse Bone Graft Study; Parker Waichman LLP Comments 3Health News:ENT and Allergy Associates Merges with Hudson Valley ENT, Adds Five Superb Physicians, Expands Overall County Presence 2Health News:ENT and Allergy Associates Merges with Hudson Valley ENT, Adds Five Superb Physicians, Expands Overall County Presence 3Health News:ENT and Allergy Associates Merges with Hudson Valley ENT, Adds Five Superb Physicians, Expands Overall County Presence 4Health News:ENT and Allergy Associates Merges with Hudson Valley ENT, Adds Five Superb Physicians, Expands Overall County Presence 5Health News:Biomet Hip Lawsuit News: Bernstein Liebhard LLP Reports on Latest Status Conference in Federal Biomet Hip Replacement Litigation 2Health News:Biomet Hip Lawsuit News: Bernstein Liebhard LLP Reports on Latest Status Conference in Federal Biomet Hip Replacement Litigation 3
... between micronutrient supplementation and reduced risk of recurrence during ... June 1 issue of The Journal of Infectious Diseases, ... tuberculosis therapy, once common before the advent of anti-TB ... therapy in most low-income countries even though poor nutrition ...
... Johnson &,Johnson will participate in the Morgan Stanley ... The Ritz-Carlton in Key Biscayne,Florida. Dominic Caruso, Vice ... Company in a session scheduled at 2:20 p.m.,(Eastern ... investors and other interested parties,by accessing the Johnson ...
... that are helping doctors diagnose and treat lung ... Lung Cancer Conference jointly organized by the European ... Association for the Study of Lung Cancer (IASLC) ... No. 81O; Friday 25th April, 16:30), Israeli researchers ...
... autism are increasingly turning to sensory integration treatment ... and theyre seeing good results. In 2007, 71 ... treatment used sensory integration methods, and 91 percent ... from Temple University researchers, presented this month at ...
... (NYSE: HRC ) fiscal 2008 second quarter earnings ... invited to view its webcast the,following morning on Wednesday, ... Release: Hill-Rom Holdings, Inc.,s Fiscal 2008 Second Quarter,Earnings Release ... released to,the public after the NYSE close on Tuesday, ...
... in OTC Private Label Market, PRINCETON, N.J., ... owned subsidiary of Ranbaxy Laboratories Limited (RLL), announced,today ... U.S. Food and Drug,Administration to manufacture and market ... Oral Solution,(Hives-Relief), 1 mg/mL (OTC). The Office of ...
Cached Medicine News:Health News:Study shows common vitamin and other micronutrient supplements reduce risks of TB recurrence 2Health News:New genetic techniques to combat lung cancer 2Health News:Autistic mannerisms reduced by sensory treatment 2Health News:Autistic mannerisms reduced by sensory treatment 3Health News:Hill-Rom Holdings, Inc. Invites You to Join Its Fiscal 2008 Second Quarter Earnings Webcast 2Health News:Ranbaxy Receives Final Approval to Manufacture and Market Cetirizine Hydrochloride Oral Solution 2
(Date:6/18/2013)... 18, 2013 Apama Medical, a privately ... of next-generation atrial fibrillation technologies, today announced the ... US Patent and Trademark Office (USPTO), titled "Low ... assemblies for use on expandable structures such as ... procedures. "We are grateful to the ...
(Date:6/18/2013)... Calif. , June 18, 2013  Isis Pharmaceuticals, Inc. ... today announced that management will present a general corporate update ... Open House on Tuesday, June 25 at 2:10 p.m. Pacific ... The agenda for the meeting is as follows: 2:00 p.m. ... of record as of April 26, 2013) 2:10 p.m. – ...
(Date:6/17/2013)... , June 17, 2013 Velplex, LLC announced ... a technology platform that connects buyers and sellers of ... an industry leader. Why? It,s because ... are intimately familiar with the dental industry. They have ... and have diligently worked to negotiate some of the ...
Breaking Medicine Technology:Isis Pharmaceuticals to Present a General Corporate Update at its 2013 Annual Meeting of Stockholders and Open House 2TopProdeals.com Rises to Top as Discount Dental Supply Leader 2
... The Clariflex® Intraocular Lens is indicated ... years of age or older in whom ... IOL is a third-generation IOL design made ... is designed both to reduce internal reflections ...
... Lenses: The Bausch & Lomb PMMA Posterior Chamber ... primary implantation for the visual correction of aphakia ... where a cataractous lens has been removed by ... be placed in the ciliary sulcus or capsular ...
... USIOL lenses are manufactured using ... processes. Perspex CQ UV PMMA ... multi-piece and single piece lenses. ... in both nonphaco and phaco ...
... II is a sterile nonpyrogenic, transparent viscoelastic ... II contains 12 mg/ml of high molecular ... hyaluronate dissolved in physiological saline. In the ... is 105,000 cps (105 Pa s) at ...
Medicine Products: